A B S T R A C T Cold-insoluble globulin (CIG), which is immunochemically indistinguishable from the fibroblast surface protein known as large external transformation-sensitive glycoprotein and fibronectin, was detected immunologically in connective tissue fractions from adult human lung. The fractions tested were (a) intact parenchyina, (b) acidic structural glycoproteins (ASG) extracted from lung parenchyma with 0.3 M acetic acid, and (c) isolated alveolar basement membrane (ABM). For comparison with ABM, preparations of human glomerular basement membrane and human trophoblast basement membrane (TBM) were tested. CIG was not detected in glomerular basement membrane but was present in large amounts in TBM. The CIG antigen could be solubilized from the parenchyma and from ABM by collagenase digestion, which indicates that CIG occurs in lung connective tissue in association with collagen. Fibrinogen antigenic determinants were present in the ASG fraction, but the question of whether CIG and fibrin(ogen) are associated in lung connective tissue requires further study. When CIG was quantified by electroimmunoassay, intact lung parenchyma contained -0.4% CIG, ASG contained 3-4.5% CIG, ABM contained 0.1-0.9% CIG, and TBM contained 1.5-7.2% CIG. The evidence suggests that CIG is a chemical constituent of lung connective tissue matrix where it may influence the function of alveoli.
INTRODUCTION
Since the early descriptions (1-5) of a major surfaceglycoprotein of fibroblasts, which is transformation sensitive, this substance has been designated in a variety of ways. These include large external transformation sensitive glycoprotein, cell surface protein, "galactoprotein a", and fibronectin. Recently, cold-insoluble globulin (CIG)l of human plasma (6, 7) has been shown to be immunochemically indistinguishable from the fibroblast surface antigen (8) and has been called plasma fibronectin. The terms CIG and fibronectin are used interchangeably in this paper.
Fibronectin appears to interact with collagen on the cell surface (9) , and was earlier shown to mediate the adhesion of fibroblasts to collagen (10) . CIG also binds to collagen (11) . Both CIG and the fibroblast antigen act as substrates for plasma transglutaminase (fibrin stabilizing factor) with the formation of high molecular weight multimers (12, 13) . This transglutaminase also covalently links CIG to fibrin.
The cell culture form of fibronectin exists as insoluble aggregates of high molecular weight on the cell surface. Although the nature of this aggregation is incompletely understood at present, it is known that disulfide bonding (14) (15) (16) ) is essential to its integrity. After isolation from the cell surface, the glycoprotein is insoluble in isotonic solutions at physiological pH (15) . Because these reactions of fibronectin with collagen and fibrin or other fibronectin molecules provide mechanisms for the synthesis of high molecular weight networks or aggregates, it is reasonable to assume that the protein may influence the organization of the connective tissue matrix and of basement membranes in organs such as the lung and placenta.
The object of this study was to examine intact, adult, human lung parenchyma and tissue fractions isolated from it for the presence of fibronectin with a specific antiserum to CIG. Alveolar basement membrane (ABM) (17) was one ofthe fractions studied and human glomerular basement membrane (GBM) as well as human trophoblast basement membrane (TBM) (18) 'Abbreviatio?ls used in this paper: ABM, alveolar basement membrane; ASG, acidic structural glycoprotein(s); CIG, cold-insoluble globulin; GBM, glomerular basement membrane; TBM, trophoblast basement membrane.
have been examined for comparison. A soluble fraction was prepared from intact lung parenchyma by extraction with 0.3 M acetic acid (19) , a procedure which had been shown to be effective in solubilizing placental villi (18) . Soluble proteins could be recovered from these extracts by reversible isoelectric precipitation at pH 4.7. This soluble fraction has been designated an acidic structural glycoprotein (ASG) fraction on the basis of its similarity to ASG fractions from lung (20) and from a variety of other tissues (21) .
METHODS
Preparation of connective tissue fractions. Lungs collected at autopsy were stored at -70°C. Each preparation was made from the lungs of a single individual who was clinically free of lung disease, except where noted, and lung tissue was normal grossly and histologically. The parenchyma was first freed of pleural membranes, large blood vessels, and bronchi, and then was washed repeatedly with 0.15 M sodium chloride followed by water to free it of blood. Aliquots were lyophilized for collagenase digestion experiments but the wet tissue was used immediately for ASG (19) or ABM (17) preparations. Two other human basement membranes, GBM and TBM (18) , were studied for comparison. Each preparation was made from tissue of a single individual.
ABM. Details of the preparation of ABM by sieving and sonication of lung parenchyma as well as methods used to solubilize it have been described (17) . Likewise, the membrane preparations from terminal villi of placenta (TBM) and from renal cortex (GBM) have been described (18) .
ASG. The ASG were extracted from washed (blood-free) lung parenchyma by stirring with 0.3 M acetic acid (6 ml/g) at 4°C for 24 h. Four extractions were carried out. The insoluble residue was lyophilized (acetic acid insoluble parenchyma).
A measured aliquot of each extract was dialyzed and lyophilized to determine the weight of parenchyma solubilized. The (6) . Plasma ofknown CIG concentration was used as a standard. The percent CIG was calculated on the basis of the weight of lyophilized parenchyma.
In a large-scale experiment, 2 g (dry weight) of acetic acid insoluble parenchyma was digested with 250 U collagenase in 100 ml buffer (23) at 37°C under toluene for 220 h. The undigested residue was removed by centrifugation at 16,000 g for 20 min and was washed once with buffer and repeatedly with water until it was salt free. The supernate, buffer wash, and first water wash were combined, dialyzed until salt free, and lyophilized. The lyophilized material was soluble in 0.087 M barbital buffer, pH 8.6 and was analyzed for CIG content by the Laurell technique (24) and for glycosaminoglyeans (vide infra).
Solubilization of CIG from basement membranes. Plasmin as well as collagenase (vide supra) was used to solubilize the basement membranes. Plasmin activated with matrixbound activator was obtained from A. B. Kabi, Stockholm, Sweden, and was used in phosphate-buffered saline, pH 7.4. Weighed aliquots of the membranes (1 mg range) were suspended at a concentration of 10 mg/ml in the appropriate buffer which contained either 125 U of collagenase or 0.5 caseinolytic U of plasmin/mg of basement membrane. Filter paper saturated with toluene was suspended in the tube which was then tightly covered and incubated at 37°C for 3 days. The undigested residue was centrifuged out and the supernates were used directly in double diffusion tests (25) or were analyzed for CIG content by the Laurell technique (24) with plasma of known CIG content as a standard. The percent CIG was calculated on the basis of the original weight of the basement membrane.
Dilute alkali (0.01 N NaOH) was also used to solubilize CIG from TBM. The membranes were suspended at a concentration of 5 mg/ml in 0.01 N NaOH and the suspension was stirred at 25°C for 24 h. The undigested residue was centrifuged out and the clear supernates were analyzed for CIG by the Laurell technique (24).
Analytical methods. The amount of protein in the supernates from the enzymatic digests was estimated by the method of Lowry et al. (26) . The amino acid analyses on the basement membranes (17, 18) and on the ASG fractions were performed on weighed samples (1-2 mg) which had been hydrolyzed in vacuo (2 ml 6 N HCl, 24 (28) were made to allow separation of hydroxyproline from aspartic acid at 55°C and for the determination of desmosine and isodesmosine. The thiobarbituric acid reaction (29) (6) and contained fibrinogen as a result ofthis absorption (Fig. 3) . The rabbit antiserum to human fibrinogen, which did not react with CIG, and the goat antiserum to human serum, were kindly provided by Dr. Konrad C. Hsu of Columbia University, College of Physicians & Surgeons, New York. The rabbit antiserum to human a2-macroglobulin was obtained from Behring Diagnostics, American Hoechst Corp., Somerville, N. J.
RESULTS
Qualitative observations with a specific antiserum to CIG. The presence of CIG in lung parenchyma is demonstrated in Fig. 1 where the precipitin line given by collagenase-solubilized parenchyma (well 1) gave a reaction of identity with reference CIG (well 2). The highly purified collagenase (Methods) also solubilized CIG from ABM (Fig. 2) . Again, a reaction of identity with reference CIG was formed.
As shown in Fig. 3 , the presence ofCIG in each ofthe ASG preparations from four different lungs (wells 2 and 4-6) was demonstrated by the clear precipitin lines which occurred with the antiserum to CIG. These were reactions of identity with reference CIG (well 1). In this figure, the ASG in wells 2, 4, and 6 were from three different normal lungs, whereas the ASG in well 5 was from a human lung which had severe interstitial fibrosis resulting from X-irradiation. No distinctions in precipitin reaction were demonstrated among these specimens. However, the ASG from two of the normal lungs and from the fibrotic lung show a double precipitin line which suggests the presence of two molecular species carrying the relevant determinants.
In well 3, antifibrinogen antiserum is reacting with soluble fibrinogen in the anti-CIG serum. The presence Cold-Insoluble Globulin (Fibronectin) in Lung of fibrinogen in the anti-CIG serum is the result of absorption (6) . Antifibrinogen also reacted with the ASG fractions placed next to it in wells 2 and 4 (normal lungs). In the specimen in well 2, the CIG determinants and the fibrinogen determinants were clearly independent. However, in the sample in well 4, this independence was not apparent.
The two ASG fractions (wells 2 and 4) were examined for the presence of fibrinogen by immunoelectrophoresis. The pattern seen in Fig. 4 was obtained in both cases. The same sample used in well 4 of Fig. 3 appears in the lower well of Fig. 4 . It was electrophoresed at pH 8.6 along with human plasma diluted 1 -*5 (upper well). Antifibrinogen was placed in the center trough. After 48 h, plasma gave an arc of the expected shape at the origin. However, the fibrinogen antigenic determinants in the ASG fractions were present on molecules which were more negatively charged than intact fibrinogen.
Quantitative results obtained with a specific anti- nondialyzable fraction was lyophilized. This fraction weighed 120 mg, or 6% of the 2 g digested. This fraction contained 5% CIG, and the CIG content of the acetic acid insoluble parenchyma was, therefore, 0.3%. The sum of CIG in the ASG and in the acetic acid insoluble parenchyma was 0.44% (Table I) . Two other preparations of lung ASG were analyzed and found to contain 3.0 and 3.9% CIG, respectively (Table I) .
CIG was present in the three ABM preparations tested, but the amounts were small and variable (0.1%, 0.35%, and 0.86%). The highest concentration of CIG was present in TBM (up to 7.2%) ( Table I) .
CIG was not detected in two different preparations of human GBM (one of the two was tested by immunodiffusion only) nor in canine GBM (Table I) .
Factors which affect the quantification. (a) The shape of the precipitin arcs given by the tissue samples (Fig. 5) (2 g ) was digested with collagenase (250 U) in 100 ml buffer (23) at 37°C under toluene for 220 h. The nondialyzable, collagenase-soluble fraction was dissolved in 0.087 M barbital buffer (pH 8.6) at a concentration of2 mg/ml. (D) TBM solubilized by plasmin: 0.93 mg TBM was digested for 64 h under toluene at 10 mg/ml in phosphate-buffered saline (pH 7.4), which contained 0.5 caseinolytic U of plasmin. The sample was diluted 1 -2 with 0.087 M barbital buffer (pH 8.6) just before electrophoresis. (E) ASG from normal human lung was dissolved in 0.087 M barbital buffer (pH 8.6) at a concentration of 5 mg/ml. different molecular species. This can be seen in Fig. 3 where a double line was given with the anti-CIG serum by three of the preparations.
Partial characterization of connective tissue fractions Basement membranes. As reported (17, 18) , both ABM and TBM had chemical compositions which differed from GBM prepared by the same methods in the same laboratory. The amount of collagen as estimated by the hydroxyproline analyses was much less in TBM and intermediate in ABM. Large amounts of an acidic glycoprotein were present in TBM. Elastin, as evidenced by the presence of desmosine and isodesmosine, was a consistent component of ABM.
Collagenase-solubilized lung parenchyma. The nondialyzable, collagenase-solubilized fraction which contained 5% CIG (vide supra) was examined for the presence of glycosaminoglycans. Both hyaluronic acid and dermatan sulfate were detected by Alcian blue staining of samples which had been electrophoresed on cellulose acetate. The fraction contained 2.3% uronic acid (32) which would indicate a glycosaminoglycan content of -7%.
Acidic structural glycoproteins. The four sequential extractions with 0.3 M acetic acid solubilized 6%, 2-3%, 1%, and 1%, respectively, of lung parenchyma. These fractions contained little or no collagen as evidenced by the absence or trace quantitites of hydroxyproline detected in the dialyzed, lyophilized extracts. The material recovered from the extracts by precipitation at pH 4.7 comprised -30% of the extracts or 3% of the parenchyma. The CIG content of the ASG fractions was 3-4.5% or 0.09-0.14% of washed parenchyma. These fractions were designated ASG fractions because the material underwent reversible isoelectric precipitation at pH 4.7, migrated with a mobility identical with or slightly lower than human a, globulin upon electrophoresis at pH 8.6, and contained carbohydrate as well as large amounts of cysteine. In Table II , an analysis of a typical ASG fraction extracted from human lung with 0.3 M acetic acid and recovered by isoelectric precipitation at pH 4.7 is shown compared with the analysis of an ASG fraction extracted from bovine lung parenchyma by Francis and Thomas (20) with 0.1 M NaBH4 in 8 M urea. Both preparations contained large amounts of aspartic acid, glutamic acid, leucine, and half-cystine; and small amounts of hexose, hexosamine, and sialic acid. Hydroxyproline, hydroxylysine, desmosine, and isodesmosine were either not detected in the preparations or were present in trace amounts. Therefore, collagen and elastin were not present. Only one serum protein was detected in ASG by double diffusion experiments and it was presumably fibronectin. This was corroborated by immunoelectrophoresis of ASG and human serum. Whereas human serum diluted 1 -* 5 gave the expected pattern of arcs with goat anti-human serum, the ASG fractions produced one arc. The ASG fractions also failed to react with specific antiserum to human a2-macroglobulin in double diffusion experiments. Antigenic determinants of fibrinogen, but not the fibrinogen molecule, were present in these ASG fractions (Figs. 3 and 4) . DISCUSSION In this study, fibronectin has been demonstrated in several fractions of adult human lung, i.e., intact parenchyma, ABM, and ASG from parenchyma. Also, an association of lung fibronectin with collagen has been demonstrated because degradation of insoluble collagen with collagenase also solubilized fibronectin and proteoglycans. The presence of CIG and its association with collagen and possibly with proteoglycans was anticipated from observations that cultured human fetal lung fibroblasts which synthesize collagen (34) and proteoglycans (35) also synthesize fibronectin (36, 37) .
Possible functions for fibronectin in lung interstitium can only be speculative. Studies offibroblasts in culture (38, 39) indicate a role for fibronectin in fibroblist attachment to a substratum, in spreading, and in the organization of the cytoskeleton. Bornstein and Ash (9) envision a model in which collagenous proteins and fibronectin form a fibrillar network on the surface of the fibroblasts and propose that this network influences the attachment of cells to a substratum. Such functions for fibronectin are consistent with the 0.4% fibronectin found in lung parenchyma in this study which is small compared to amounts of recognized structural fibrillar proteins such as collagen and elastin. However, in view of the factors which affect the quantification, 0.4% fibronectin is proposed as an approximate value.
Acidic structural glycoproteins are associated with collagen and elastin in a variety of connective tissues (21, 40) and it has been suggested they are structural components of the elastic fiber microfibrils (41) . In bovine lung parenchyma they comprise 15 .5% of the dry weight of salt-extracted, delipidated parenchyma (20) . The methods now in use for the preparation of ASG, which include extraction with 8 M urea, reduction and alkylation of disulfide bonds (42) (44) . The isolation and characterization of various components of the ASG fraction, especially those which have been shown in this study to carry the antigenic determinants of fibrinogen, will be the object of a future study.
The finding that GBM does not contain fibronectin was a surprising one in view of an earlier report (45) which demonstrated the presence of fibronectin in all limiting membranes of the developing chick embryo by use of the indirect immunofluorescence technique. However, the data are in complete agreement with more recent immunofluorescence results from two different laboratories (46) (47) (48) which show an absence of fibronectin from human GBM. The fibronectin content of ABM and TBM in this study showed wide variation among preparations, each from a separate lung or placenta. This variation is, at present, unexplained. It may reflect the activity of proteases and inhibitors in the individual organs. Alternatively, it could mean that fibronectin is not an integral part of ABM or TBM, but is peripherally associated in a structure which is variably removed by the preparative procedures used, e.g., sonication.
While it is recognized that fibronectin combines with fibrin, the nature of its association with fibrinogen and collagen remains unknown. However, these associations afld its ability to form multimers in the presence offibrin-stabilizing factor suggest a functional significance in membranes. The basement membranes of lung alveoli, alveolar capillaries, and of placenta are selective in membrane transport. The relative abundance of fibronectin in the membranes of alveoli and placenta in contrast to its absence in GBM may have important functional as well as structural significance for these different organs.
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